ADC最前線

轉移性泌尿上皮癌治療新契機-抗體藥物複合體(ADC)

Antibody-Drug Conjugates in Bladder Cancer - ASCO 2022 Highlight

Antibody-Drug Conjugates in Bladder Cancer - Study EV-103 Cohort K

ADC as Novel Options in Cisplatin-lneligible UC

Combination therapies with immunotherapy and ADCs prolong overall survival in 1st line la/m UC

Tailoring ADCs Cancer Treatment for individual Patients with LA/mUC

1L mUC 突破療效新境界:ADC+IO 先發投出最速球

Master Club -ADC 最前線-王牌教練開講